| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 6, 2026 | ±2.2% | +0.3% | over-priced |
| February 6, 2026 | ±2.9% | +2.8% | over-priced |
| August 6, 2025 | ±2.4% | +0.1% | over-priced |
| May 7, 2025 | ±2.4% | +1.5% | over-priced |
| February 7, 2025 | ±2.5% | -0.6% | over-priced |
| August 6, 2024 | ±4.1% | +1.4% | over-priced |
| May 7, 2024 | ±1.6% | -0.3% | over-priced |
| February 7, 2024 | ±2.7% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.72 | $4.3B | $544M |
| Q1 FY2026 | $2.79 | $4.2B | $563M |
| Q4 FY2025 | $2.95 | $4.2B | $604M |
| Q3 FY2025 | $2.12 | $3.8B | $436M |
Raymond James Financial, Inc. (RJF) reports in 75 days, with the next report estimated for August 27, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced RJF's earnings risk. Fundamentals into the print: EPS up 15.3% year-over-year, revenue up 10.8%. QuantLogix's live 5-factor engine currently reads RJF as a buy at 54/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →